Viewing Study NCT06360406


Ignite Creation Date: 2025-12-26 @ 5:24 PM
Ignite Modification Date: 2026-02-06 @ 3:57 AM
Study NCT ID: NCT06360406
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2024-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-World Treatment Study of Koselugo (Selumetinib)
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurofibromatosis 1 View
None Neurofibroma, Plexiform View
Keywords: